Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 1,793Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Zytiga

02 2Zytiga

PharmaCompass

01

Brand Name : Zytiga

Abiraterone Acetate

arrow
Immuno-Oncology 360
Not Confirmed

Brand Name : Zytiga

arrow
Immuno-Oncology 360
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 2,470

2019 Revenue in Millions : 2,795

Growth (%) : -12

blank

02

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

03

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

Brand Name : Zytiga

arrow
Cancer Research
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 1,770

2021 Revenue in Millions : 2,297

Growth (%) : -23

blank

04

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

05

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

06

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

07

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

08

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

09

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

Brand Name : Zytiga

arrow
Cancer Research
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 3,498

2017 Revenue in Millions : 2,505

Growth (%) : 40%

blank

10

Brand Name : Zytiga

Abiraterone Acetate

arrow
Cancer Research
Not Confirmed

Brand Name : Zytiga

arrow
Cancer Research
Not Confirmed

Abiraterone Acetate

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 2,795

2018 Revenue in Millions : 3,498

Growth (%) : -20

blank